SRPT trade ideas
SRPT - Downward channel breakout Long from $35.57 to $44.63 SRPT seems breaking out a downward channel formation, and if it can reach its Channel breakout target, it will breakout long term resistance & can continue higher.
* Trade Criteria *
Date First Found- June 21, 2017
Pattern/Why- Downward channel breakout Long
Entry Target Criteria- Break of $35.57
Exit Target Criteria- 1st Target $41.33, 2nd Target $44.63
Stop Loss Criteria- $33.12
Please check back for Trade updates. (Note: Trade update is little delayed here.)
SRPT LONG LONG LONG!1. Downward trend has ended. SRPT seems to be building a upward trend.
2. Stochastic RSI was at oversold area few days ago and it is crossing up to purple zone. It confirms the demand.
3. CCI is showing similar behavior, few days ago was oversold and confirms demand.
4. SRPT just hit support at $28-$30 and it is channeling up if you look at the lines I drew.
5. MACD blue line is not even crossing orange line yet. Once cross there will be a hUGE price surge. You can buy now and sell it high at intraday right when blue crosses orange line and make money off those traders who use MACD indicators!
I will let you put the price to sell but right now the setup looks very good.
You might think same can be said on May 15 and it failed hard. However on May 15, SRPT lacked the confirmation from CCI and the support/resistance line.
SRPT- going long Friday!!On Finviz.com and other research, a new medication was approved today, should be reflected in PA tomorrow. Some analyzes say stock could go up 200%.
Will be looking to buy stock shares and/or put options for ether weekly or monthly in this stock.RSI is pointing up and trend line on chart looks great. Look where SRPT has been, it has a lot of room for bulls to run. Please do your own research and homework on all trading, if this stock fits your plans, then make an entry plan and exit plan--- that fits your plan. Wish you well and keep on smiling.
Watch the TriangleThis is one of the better looking drug stocks. There is very little resistance over the trendline.
Expected Major Breakout With 50% On This Stock...After extensive research, I believe Sarepta Therapeutics Inc (NASDAQ:SRPT) will likely breakout this week. The chart has consolidated for a long period, slowly falling from over $60 after the last fantastic bit of drug news. The breakout trend line seen in the chart below continues to be hammered and should give way on the next move up. I also believe there will be likely drug news in the next few weeks which will propel the stock to as high as $45. That is a 50% upside target. This company is on the cutting edge of multiple biotech drug treatments and at its current valuation, offers an amazing opportunity. I am looking to buy some this week, the second the stock crosses above the breakout trend line.
View my verified performance here: verifiedinvesting.com
Biotech $SRPT Crushed On Bigger Loss, See Buy Levels HereAfter the stock market closed on Tuesday, Sarepta Therapeutics Inc (NASDAQ:SRPT) reported a bigger-than-expected loss of $88.5 million or $1.62 per share. In addition, investors are questioning their ability to fully launch and profit from upcoming drugs, offsetting future losses as they burn through cash. The stock took a beating after-hours, dropping almost 15% to below $27 per shares. As investors are freaking out, those of us not currently invested in the stock have a chance to make a wise decision. The company still has huge drugs in its pipeline and over $300 million in cash. The key is finding the right buy level. The first major support on the stock is at $24.00. That would be the first spot to accumulate a small position. I would recommend accumulating all the way down to $20, then looking for positive drug news to drive the stock above $40.
Stock chart analysis on Sarepta Therapeutics after crushed
Possible Long OpportunityNASDAQ:SRPT is already almost oversold but I think $24.2 would be a good level to buy for a long position, lets see...
$SRPT SRPT short tomorrow$SRPT SRPT If this baby gaps up tomorrow I'm going to go short if it spikes up into a whole dollar, then I will have my resistance right above that
OPENING: SRPT JAN 2017 8 LONG PUTShooting for an .08 ($8) debit fill here. It's a lotto trade (which I hardly ever do), but I think that the drug will ultimately not be approved.
The potential profit is $795/contract, but that's if the stock goes to "0." Additionally, it will only "play out" if there is news prior to expiry. Otherwise, it'll stay way up here.
Vega is the candyIV at 303% when historical volatility barely makes it to 200% makes this trade a pretty easy one imo. There's a very minimal chance that a gap would find higher values of $40 - or less than $4. Anyway, I'm not holding this options once the theta fat is gone.
Sarepta Therapeutics: Patience Will Not Be Rewarded
Stock Falls, Janney: 'Stay on the Sidelines'
SOLD SRPT AUG 26TH 35 CALL... for a 2.85 ($285)/contract credit.
This will complete an Aug 26th 10/35 short strangle worth 4.15 in credit ($415)/contract, which I'll shoot to take off at 50% max profit.
Because I already had the 10 short put on, this doesn't cost me any additional buying power. This will also give me some protection to the short side, since I think that this is more likely to implode than explode. Naturally, I hope to be out before any of that "splosion" occurs.
BOUGHT TO COVER SRPT SEPT 16TH 8/40 SHORT STRANGLEMmm. Must have gotten busy and not posted this one. In any event, I legged into these two sides separately, the 8 first and then the 40 after it ripped somewhat higher.
The whole burrito was worth 5.82 in credito. Closing out here for a 4.60 debit nets me $122/contract in profit. This thing is "wicked illiquid", so I figured I get while the gettin' was good ... .
PREMIUM SELLING: SOLD SRPT AUG 26TH 10 SHORT PUT... for a 1.30 ($130)/contract credit. I probably could have worked for a better fill by $5-$10, but wanted to get this last trade on before the close.
Metrics:
Probability of Profit: 86%
Max Profit: $130/contract
Max Loss: Undefined
Buying Power Effect: $100/contract
Break Even: 8.70
Notes: I'll look to take this off at 50% max. It's a trade, not an investment ... .
